Axonis Therapeutics
PrivateLast Round
Series A
Oct 30, 2024
Total Funding Raised
$141.7M
Company Overview
Axonis Therapeutics is a biotechnology company developing first-in-class oral small molecule therapies targeting KCC2 to treat central nervous system disorders such as epilepsy, chronic pain, and spinal cord injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axonis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Axonis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 30, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Seed | Jul 14, 2021 | ||||
| Seed | May 28, 2020 |
Key People
Founding team and executive leadership
Axonis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| SCI Ventures | Series A |
| CURE Epilepsy | Grant |
| Perceptive Advisors | Series A |
| Acks | Series A |
| NIH RADx | Grant |
| Cormorant Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Translating discoveries from Boston Children's Hospital, Harvard, and Laval University.
- Jul 3, 2025
Grew 3D brain organoids in space to test new neurological drugs.
Axonis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axonis Therapeutics's valuation, stock price, and market status.